ArticleThe Journal of nutrition2026
Novel Erythroid Indices Have Better Prognostic Accuracy than Conventional Erythroid Indices for Early Diagnosis of Iron Deficiency and Associated Brain Metabolomic Changes in Nonhuman Primate Infants.
Article in The Journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHemoglobin (Hgb) lacks sensitivity for early detection of iron deficiency (ID) and associated brain metabolic dysregulation in infancy. The utility of newer erythroid indices for early diagnosis of ID and altered brain metabolome is unknown.
objectivesThis study aimed to compare conventional and newer erythroid indices for predicting ID, anemia, and altered brain metabolome using a nonhuman primate model of infantile ID.
methodsSerum iron panel and erythroid indices were determined at 2 wk and 2, 4, and 6 months in male and female infant rhesus monkeys born to mothers consuming a 180 mg Fe/kg diet (n = 51). Cerebrospinal fluid (CSF) metabolomic profiles were obtained at 2 and 4 months in a subset of ID and iron-sufficient infants (n = 10). Accuracy for prediction of ID [transferrin saturation (TSAT) <20%], anemia (Hgb <10 g/dL), and CSF metabolomic changes was evaluated using t tests, regression models, and canonical correlation analysis (CCA).
resultsTwenty infants (39.2%) developed ID and 13 (25.5%) progressed to anemia. At 2 wk, newer erythroid indices-immature reticulocyte fraction, reticulocyte hemoglobin equivalent (RET-He), and difference between hemoglobin in reticulocytes and that in mature red blood cells (Delta-He)-were altered in infants who subsequently developed ID, and, along with percentage hypohemoglobinized and hyperhemoglobinized erythrocytes, predicted the future likelihood of ID and anemia (false discovery rate <0.05). Hgb was not predictive of ID or anemia until 2 mo. Among erythroid indices, Delta-He was the best predictor, with an accuracy of 84% for both, and was comparable with TSAT. CCA demonstrated correlations between 4-mo CSF metabolomic profile and 2-wk (r = 0.71), 2-mo (r = 0.82), and 4-mo (r = 0.79) erythroid profiles. Mean corpuscular hemoglobin and RET-He were the largest contributors to the correlations between the 2-wk and 2-mo erythroid profiles and the 4-mo CSF metabolomic profile.
conclusionsNewer erythroid indices detect ID, anemia, and brain metabolomic alterations earlier than conventional indices in infant monkeys.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.